<SEC-DOCUMENT>0001213900-24-014908.txt : 20240216
<SEC-HEADER>0001213900-24-014908.hdr.sgml : 20240216
<ACCEPTANCE-DATETIME>20240216161523
ACCESSION NUMBER:		0001213900-24-014908
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240216
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240216
DATE AS OF CHANGE:		20240216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			180 Life Sciences Corp.
		CENTRAL INDEX KEY:			0001690080
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				813832378
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38105
		FILM NUMBER:		24648518

	BUSINESS ADDRESS:	
		STREET 1:		3000 EL CAMINO REAL
		STREET 2:		BLDG 4, STE 200
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94306
		BUSINESS PHONE:		650-507-0669

	MAIL ADDRESS:	
		STREET 1:		3000 EL CAMINO REAL
		STREET 2:		BLDG 4, STE 200
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94306

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KBL MERGER CORP. IV
		DATE OF NAME CHANGE:	20161115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea193928-8k_180life.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:ATNF="http://180lifesciences.com/20240216">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_ATNF_180lifesciences.com_20240216 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20240216_20240216 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001690080 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-02-16" name="dei:AmendmentFlag" id="ixv-523">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-02-16" name="dei:EntityCentralIndexKey" id="ixv-524">0001690080</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="atnf-20240216.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-02-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001690080</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-16</xbrli:startDate>
        <xbrli:endDate>2024-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-162024-02-16_custom_CommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001690080</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATNF:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-16</xbrli:startDate>
        <xbrli:endDate>2024-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-162024-02-16_custom_WarrantsToPurchaseSharesOfCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001690080</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATNF:WarrantsToPurchaseSharesOfCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-16</xbrli:startDate>
        <xbrli:endDate>2024-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>SECURITIES AND EXCHANGE
COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>FORM&#160;<span id="xdx_902_edei--DocumentType_c20240216__20240216_zdbtZey3xFQl"><ix:nonNumeric contextRef="AsOf2024-02-16" name="dei:DocumentType" id="ixv-560">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>PURSUANT TO SECTION
13 OR 15(d) OF THE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>SECURITIES EXCHANGE
ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">Date of Report (Date of
earliest event reported):&#160;<b><span id="xdx_904_edei--DocumentPeriodEndDate_c20240216__20240216_zmkidOobeYd5"><ix:nonNumeric contextRef="AsOf2024-02-16" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-561">February 16, 2024</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b><span style="text-decoration: underline"><span id="xdx_90C_edei--EntityRegistrantName_c20240216__20240216_zWo2CmLVXiA9"><ix:nonNumeric contextRef="AsOf2024-02-16" name="dei:EntityRegistrantName" id="ixv-562">180 LIFE SCIENCES
CORP.</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">(Exact Name of Registrant
as Specified in Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20240216__20240216_zkikHIP8thFa"><ix:nonNumeric contextRef="AsOf2024-02-16" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-563">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_901_edei--EntityFileNumber_c20240216__20240216_z4AlS93QDtV2"><ix:nonNumeric contextRef="AsOf2024-02-16" name="dei:EntityFileNumber" id="ixv-564">001-38105</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20240216__20240216_zbEM2c4rfUM6"><ix:nonNumeric contextRef="AsOf2024-02-16" name="dei:EntityTaxIdentificationNumber" id="ixv-565">90-1890354</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(State or Other Jurisdiction<br/>
of Incorporation)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(IRS Employer<br/>
Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 49%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20240216__20240216_zU2lmKot4H8b"><ix:nonNumeric contextRef="AsOf2024-02-16" name="dei:EntityAddressAddressLine1" id="ixv-566">3000 El Camino Real</ix:nonNumeric></span>,<span id="xdx_906_edei--EntityAddressAddressLine2_c20240216__20240216_zwJlpjlF8g95"><ix:nonNumeric contextRef="AsOf2024-02-16" name="dei:EntityAddressAddressLine2" id="ixv-567">&#160;Bldg. 4</ix:nonNumeric></span>,<span id="xdx_904_edei--EntityAddressAddressLine3_c20240216__20240216_ziF6uobTZZn3"><ix:nonNumeric contextRef="AsOf2024-02-16" name="dei:EntityAddressAddressLine3" id="ixv-568">&#160;Suite
    200</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90E_edei--EntityAddressCityOrTown_c20240216__20240216_zS8KC7KqFou9"><ix:nonNumeric contextRef="AsOf2024-02-16" name="dei:EntityAddressCityOrTown" id="ixv-569">Palo
    Alto</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressStateOrProvince_c20240216__20240216_zQ7GCv9k3rWg"><ix:nonNumeric contextRef="AsOf2024-02-16" name="dei:EntityAddressStateOrProvince" id="ixv-570">CA</ix:nonNumeric></span></b></p></td>
    <td style="vertical-align: bottom; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 49%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressPostalZipCode_c20240216__20240216_zmcv1cUT0OU3"><ix:nonNumeric contextRef="AsOf2024-02-16" name="dei:EntityAddressPostalZipCode" id="ixv-571">94306</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(Address of Principal Executive Offices)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Registrant&#8217;s telephone
number, including area code:&#160;<b><span style="text-decoration: underline">(<span id="xdx_905_edei--CityAreaCode_c20240216__20240216_z0izsJM2tcHj"><ix:nonNumeric contextRef="AsOf2024-02-16" name="dei:CityAreaCode" id="ixv-572">650</ix:nonNumeric></span>)&#160;<span id="xdx_900_edei--LocalPhoneNumber_c20240216__20240216_zrWWdj8BmJG7"><ix:nonNumeric contextRef="AsOf2024-02-16" name="dei:LocalPhoneNumber" id="ixv-573">507-0669</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions (<i>see&#160;</i>General Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15pt; text-align: justify; text-indent: -0.15pt; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--WrittenCommunications_c20240216__20240216_zluWqkr14g8c"><ix:nonNumeric contextRef="AsOf2024-02-16" format="ixt:booleanfalse" name="dei:WrittenCommunications" id="ixv-574">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--SolicitingMaterial_c20240216__20240216_zJyMepHJKOk4"><ix:nonNumeric contextRef="AsOf2024-02-16" format="ixt:booleanfalse" name="dei:SolicitingMaterial" id="ixv-575">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--PreCommencementTenderOffer_c20240216__20240216_zh1osH1yj3f9"><ix:nonNumeric contextRef="AsOf2024-02-16" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer" id="ixv-576">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--PreCommencementIssuerTenderOffer_c20240216__20240216_zGTFXEn2kgNj"><ix:nonNumeric contextRef="AsOf2024-02-16" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer" id="ixv-577">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Securities registered
pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="white-space: nowrap; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="white-space: nowrap; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_907_edei--Security12bTitle_c20240216__20240216__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zmO7NZQbmEPg"><ix:nonNumeric contextRef="From2024-02-162024-02-16_custom_CommonStockParValue0.0001PerShareMember" name="dei:Security12bTitle" id="ixv-578">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90E_edei--TradingSymbol_c20240216__20240216__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zM8ozdaG4Vqe"><ix:nonNumeric contextRef="From2024-02-162024-02-16_custom_CommonStockParValue0.0001PerShareMember" name="dei:TradingSymbol" id="ixv-579">ATNF</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">The <span id="xdx_906_edei--SecurityExchangeName_c20240216__20240216__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_za7SciZO94Ag"><ix:nonNumeric contextRef="From2024-02-162024-02-16_custom_CommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-580">NASDAQ</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_903_edei--Security12bTitle_c20240216__20240216__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseSharesOfCommonStockMember_zq6hkzWXsF1c"><ix:nonNumeric contextRef="From2024-02-162024-02-16_custom_WarrantsToPurchaseSharesOfCommonStockMember" name="dei:Security12bTitle" id="ixv-581">Warrants to purchase shares of Common Stock</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_903_edei--TradingSymbol_c20240216__20240216__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseSharesOfCommonStockMember_z6sLXZW9RtS3"><ix:nonNumeric contextRef="From2024-02-162024-02-16_custom_WarrantsToPurchaseSharesOfCommonStockMember" name="dei:TradingSymbol" id="ixv-582">ATNFW</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">The <span id="xdx_90D_edei--SecurityExchangeName_c20240216__20240216__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseSharesOfCommonStockMember_zi1azR5uDdEi"><ix:nonNumeric contextRef="From2024-02-162024-02-16_custom_WarrantsToPurchaseSharesOfCommonStockMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-583">NASDAQ</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter)
or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Emerging growth company&#160;<span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20240216__20240216_zJ7EqIiyoEy5"><ix:nonNumeric contextRef="AsOf2024-02-16" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany" id="ixv-584">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 5.02 Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="background-color: white">On
February 16, 2024, at a Special Meeting (the &#8220;<span style="text-decoration: underline">Special Meeting</span>&#8221;) of the stockholders of 180 Life Sciences Corp. (the
&#8220;<span style="text-decoration: underline">Company,</span>&#8221; &#8220;<span style="text-decoration: underline">we,</span>&#8221; &#8220;<span style="text-decoration: underline">our,</span>&#8221; or &#8220;<span style="text-decoration: underline">us</span>&#8221;)</span>, the stockholders
of the Company approved the Second Amendment (&#8220;<span style="text-decoration: underline">Second Amendment</span>&#8221;) to the First Amended and Restated 180 Life Sciences
Corp. 2022 Omnibus Incentive Plan (the First Amended and Restated 2022 Omnibus Incentive Plan, as amended by the Second Amendment, the
&#8220;<span style="text-decoration: underline">OIP</span>&#8221;) in accordance with the voting results set forth below under&#160;<span style="text-decoration: underline">Item&#160;5.07</span>. The Second Amendment
was originally approved by the Board of Directors of the Company on December 13, 2023, subject to stockholder approval and the Second
Amendment became effective at the time of stockholder approval.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The material terms of the
OIP, as amended by the Second Amendment, were described in the Company&#8217;s&#160;Definitive Proxy Statement on Schedule 14A&#160;(the
&#8220;<span style="text-decoration: underline">Proxy Statement</span>&#8221;) under the caption &#8220;<span style="text-decoration: underline">Proposal 2 &#8211; Adoption of the Second Amendment to the 180 Life
Sciences Corp. 2022 Omnibus Incentive Plan</span>&#8221; filed with the Securities and Exchange Commission (SEC) on December 26, 2023. Awards
under the OIP may be made in the form of performance awards, restricted stock, restricted stock units, stock options, which may be either
incentive stock options or non-qualified stock options, stock appreciation rights, other stock-based awards and dividend equivalents.
Awards are generally non-transferable. Subject to adjustment in connection with the payment of a stock dividend, a stock split or subdivision
or combination of the shares of common stock, or a reorganization or reclassification of the Company&#8217;s common stock, the aggregate
number of shares of common stock which may be issued pursuant to awards under the OIP is 4,249,933. The 4,249,933 share limit also applies
to the total number of incentive stock options which may be awarded pursuant to the terms of the OIP. The Second Amendment increased the
maximum number of shares available to be issued under the OIP from 470,000 shares to 4,249,933 shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Employees, non-employee
directors, and consultants of the Company and its subsidiaries are eligible to participate in the OIP. Incentive stock options may be
granted under the OIP only to employees of our company and its subsidiaries. Employees, directors and consultants of our company and its
affiliates are eligible to receive all other types of awards under the OIP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The above description of
the Second Amendment and the OIP does not purport to be complete, and is qualified in its entirety by reference to the full text of the
Second Amendment and the OIP as amended by the Second Amendment, which are attached hereto as&#160;<span style="text-decoration: underline">Exhibits 10.1</span>&#160;and&#160;<span style="text-decoration: underline">10.2</span>,
and are incorporated by reference into this&#160;<span style="text-decoration: underline">Item 5.02</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 5.07. Submission of Matters to a Vote of Security Holders.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="background-color: white">At
the Special Meeting,</span> stockholders representing 4,319,708 shares of the Company&#8217;s capital stock entitled to vote at the
Special Meeting were present in person or by proxy representing 43.1% of the voting shares issued and outstanding on the record date
of December 18, 2023, and constituting a quorum to conduct business at the Special Meeting. The following sets forth the matters that
were voted upon by the Company&#8217;s stockholders at the Special Meeting and the voting results for such matters. These matters are
described in more detail in the Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">At the Special Meeting, stockholders
approved the following proposals, which are set forth in their entirety below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">1.</span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Proposal No. 1:</b>&#160;Approval
of an amendment to our Second Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our issued
and outstanding shares of our common stock, par value $0.0001 per share, by a ratio of between one-for-four to one-for-forty, inclusive,
with the exact ratio to be set at a whole number to be determined by our Board of Directors or a duly authorized committee thereof in
its discretion, at any time after approval of the amendment and prior to February 16, 2025:</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Against</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Abstentions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Broker Non-Votes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,662,372</span></td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">653,782</span></td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,554</span></td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center">&#8212;</td><td style="width: 1%; text-align: center">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">More votes were cast for approval
of Proposal No. 1, then against Proposal No. 1, and as such Proposal No. 1 was approved at the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Proposal No. 2:</b>&#160;Approval
of the adoption of the Second Amendment to the 180 Life Sciences Corp. 2022 Omnibus Incentive Plan:</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Against</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Abstentions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Broker Non-Votes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">531,011</span></td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">256,738</span></td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,263</span></td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center">792,012</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Proposal No. 2 was approved
by approximately 67.0% of the votes cast on the proposal at the Special Meeting, and as such Proposal No. 2 was approved at the Special
Meeting.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">3.</span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Proposal No. 3:</b>&#160;Approval
of the issuance of shares of our common stock, $0.0001 par value per share, in excess of 19.99% of the issued and outstanding shares
of our common stock, upon the exercise of pre-funded warrants to purchase up to 4,886,878 shares of common stock, with an exercise price
of $0.0001 per share; and warrants to purchase up to 18,128,196 shares of common stock, with an exercise price of $0.17 per share (collectively,
the &#8220;<span style="text-decoration: underline">Warrants</span>&#8221;), at a price less than the Minimum Price as defined by and in accordance with Nasdaq Listing Rule 5635(d):</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Against</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Abstentions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Broker Non-Votes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 23%; text-align: center">611,576</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">175,457</span></td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center">4,979</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center">792,012</td><td style="width: 1%; text-align: center">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Proposal No. 3 was approved
by approximately 77.2% of the votes cast on the proposal at the Special Meeting, and as such Proposal No. 3 was approved at the Special
Meeting.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">4.</span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Proposal No. 4:</b>&#160;Approval
of the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time
of the Special Meeting to approve Proposal Nos. 1 and 3 above:</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Against</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Abstentions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Broker Non-Votes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,762,247</span></td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center">552,370</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,091</span></td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center">&#8212;</td><td style="width: 1%; text-align: center">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">While Proposal No. 4 was approved,
because Proposal Nos. 1 and 3 were also approved, the approval of Proposal No. 4 had no effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 8.01. Other Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The
information provided in&#160;<span style="text-decoration: underline">Item 5.03</span>&#160;is hereby incorporated by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">As
a result of the approval of Proposal No. 3 above, the Warrants are now exercisable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(d) Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; width: 9%"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left; vertical-align: bottom; width: 90%"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-size: 10pt">10.1*</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt"><a href="ea193928ex10-1_180life.htm">Second Amendment to 180 Life Sciences Corp. 2022 Omnibus Incentive Plan</a></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-size: 10pt">10.2*</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt"><a href="ea193928ex10-2_180life.htm">Second Amended and Restated 180 Life Sciences Corp. 2022 Omnibus Incentive Plan</a></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-size: 10pt">Filed herewith.</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>180 LIFE SCIENCES CORP.</b></span></td></tr>
  <tr>
    <td style="width: 60%">&#160;</td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 36%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Date: February 16, 2024</span></td>
    <td><span style="font-size: 10pt">By:&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><i>/s/ James N. Woody, M.D., Ph.D.</i></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">James N. Woody, M.D., Ph.D.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">4</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea193928ex10-1_180life.htm
<DESCRIPTION>SECOND AMENDMENT TO 180 LIFE SCIENCES CORP. 2022 OMNIBUS INCENTIVE PLAN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><B>SECOND AMENDMENT TO<BR>
180 LIFE SCIENCES CORP.<BR>
2022 OMNIBUS INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">This
Second Amendment (&ldquo;<U>Second Amendment</U>&rdquo;) to the First Amended and Restated 180 Life Sciences Corp. 2022 Omnibus Incentive
Plan (the &ldquo;<U>2022 OIP</U>&rdquo;), is made and adopted by the Board of Directors of 180 Life Sciences Corp., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), on December 13, 2023, effective as of the date approved by stockholders of the Company at a duly called
meeting of stockholders (the &ldquo;<U>Second Amendment Date</U>&rdquo;). Capitalized terms used in this Second Amendment and not otherwise
defined herein shall have the meanings ascribed to such terms in the 2022 OIP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">A.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company currently maintains the 2022 OIP.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 9pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">B.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Board believes it is in the best interests of the Company and its stockholders to amend the 2022 OIP to increase the Share Limit and the ISO Limit and to incorporate the other terms and conditions set forth herein.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><B>AMENDMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The 2022 OIP is hereby
amended as follows, effective as of the date of the Second Amendment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">1.</FONT>
<U>Section 3.1(a)</U>. Section 3.1(a) of the 2022 OIP is hereby deleted and replaced in its entirety with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&ldquo;(a)
Subject to Section 3.3 and Section 3.6, the aggregate number of Shares which may be issued under this Plan shall be 4,249,933 (the&nbsp;<B><U>&ldquo;Share
Limit</U></B>&rdquo;). All of the Shares reserved under the Plan may be issued in the form of Incentive Stock Options under the Plan,
subject to the limitation set forth in Section 3.6. The Shares issued under the Plan may be authorized but unissued, or reacquired Company
Common Stock. No provision of this Plan shall be construed to require the Company to maintain the Shares in certificated form. Unless
the Administrator shall determine otherwise, (x) Awards may not consist of fractional shares and shall be rounded down to the nearest
whole Share, and (y) fractional Shares shall not be issued under the Plan (and shall instead also be rounded as aforesaid).&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">2.</FONT> <U>Section 3.6</U>. Section 3.6 of the 2022 OIP is hereby deleted and replaced in its entirety with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&ldquo;Section
3.6 <U>Maximum Number of Incentive Stock Options</U>. Notwithstanding the Share Limit, and subject to adjustment in accordance with
Section 3.3 hereof, the maximum number of Shares that may be granted in connection with, and issued pursuant to the exercise of,
Incentive Stock Options granted under this Plan is 4,249,933 shares (the&nbsp;&ldquo;<B><U>ISO Limit</U></B>&rdquo;).&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">3. This
Second Amendment shall be and, as of the Second Amendment Date, is hereby incorporated in and forms a part of the 2022 OIP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">4.</FONT> <FONT STYLE="font-size: 10pt">Except as expressly provided herein, all terms and conditions of the 2022 OIP shall remain in full force and effect.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ea193928ex10-2_180life.htm
<DESCRIPTION>SECOND AMENDED AND RESTATED 180 LIFE SCIENCES CORP. 2022 OMNIBUS INCENTIVE PLAN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECOND AMENDED AND RESTATED&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>180 LIFE SCIENCES CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>2022 OMNIBUS INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>Originally Adopted by the Board of Directors
on April 26, 2022 and the Stockholders on June 14, 2022</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>&nbsp;Amended and Restated by the Stockholders
on July 6, 2023 and February 16, 2024</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>PURPOSES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Second Amended and Restated
180 Life Sciences Corp. 2022 Omnibus Incentive Plan, as may be amended from time to time (the &ldquo;<B><U>Plan</U></B>&rdquo;), is intended
to promote the interests of 180 Life Sciences Corp. (the &ldquo;<B><U>Company</U></B>&rdquo;) and its Subsidiaries (as defined below)
and its stockholders by (i) attracting and retaining directors, executive officers, employees and consultants of outstanding ability;
(ii) motivating such individuals by means of performance-related incentives to achieve the longer-range performance goals of the Company
and its Subsidiaries; and (iii) enabling such individuals to participate in the long-term growth and financial success of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Article I<BR>
<U>Definitions</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Whenever the following terms
are used in this Plan, they shall have the meanings specified below unless the context clearly indicates to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.1 &ldquo;<B><U>Administrator</U></B>&rdquo;
means the Board or the Compensation Committee, as determined by the Board from time to time. In exercising its discretion hereunder, the
Board shall endeavor to cause the Administrator to satisfy any requirements applicable to qualify for an exemption available under Rule
16b-3 promulgated under the Exchange Act or any other regulatory or administrative requirements that may be applicable with respect to
Awards granted hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.2 &ldquo;<B><U>Affiliate</U></B>&rdquo;
means, with respect to any Person, any other Person directly or indirectly controlling, controlled by or under common control with, such
Person where &ldquo;control&rdquo; (including the terms &ldquo;controlling,&rdquo; &ldquo;controlled by,&rdquo; and &ldquo;under common
control with&rdquo;) means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies
of a Person, whether through the ownership of securities, by contract, or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.3 &ldquo;<B><U>Alternative
Award</U></B>&rdquo; has the meaning set forth in Section 10.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.4 &ldquo;<B><U>Alternative
Performance Awards</U></B>&rdquo; has the meaning set forth in Section 10.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.5 &ldquo;<B><U>Award</U></B>&rdquo;
means any Option, Restricted Stock, Restricted Stock Unit, Performance Award, SAR, Dividend Equivalent or other Stock-Based Award granted
to a Participant pursuant to the Plan, including an Award combining two or more types of Awards into a single grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.6 &ldquo;<B><U>Award
Agreement</U></B>&rdquo; means any written agreement, contract or other instrument or document evidencing an Award, including through
an electronic medium. The Administrator may provide for the use of electronic, internet or other non-paper Award Agreements, and the use
of electronic, internet or other non-paper means for the Participant&rsquo;s acceptance of, or actions under, an Award Agreement unless
otherwise expressly specified herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.7 &ldquo;<B><U>Board</U></B>&rdquo;
means the Board of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.8 [Reserved]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 1 of 17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.9 &ldquo;<B><U>Cause</U></B>&rdquo;
means, unless otherwise provided in the Award Agreement, any of the following: (A) the Participant&rsquo;s commission of a crime involving
fraud, theft, false statements or other similar acts or commission of any crime that is a felony (or comparable classification in a jurisdiction
that does not use these terms); (b) the Participant&rsquo;s engaging in any conduct that constitutes an employment disqualification under
applicable law with respect to a material portion of the Participant&rsquo;s work duties; (c) the Participant&rsquo;s willful or grossly
negligent failure to perform his or her material employment-related duties for the Company Group, or willful misconduct in the performance
of such duties; (d) the Participant&rsquo;s material violation of any Company or Subsidiary policy as in effect from time to time; (e)
the Participant&rsquo;s engaging in any act or making any public statement that materially impairs, impugns, denigrates, disparages or
negatively reflects upon the name, reputation or business interests of the Company or its Subsidiaries; or (f) the Participant&rsquo;s
material breach of any Award Agreement, employment agreement, or noncompetition, nondisclosure or nonsolicitation agreement to which the
Participant is a party or by which the Participant is bound;&nbsp;<U>provided</U>&nbsp;that in the case of any Participant who, as of
the date of determination, is a party to an effective services, severance, consulting or employment agreement with the Company or any
Subsidiary of the Company that employs such individual, &ldquo;Cause&rdquo; has the meaning, if any, specified in such agreement. A termination
for Cause shall be deemed to include a determination by the Administrator following a Participant&rsquo;s termination of employment that
circumstances existing prior to such termination would have entitled the Company or one of its Subsidiaries to have terminated such Participant&rsquo;s
employment for Cause. All rights a Participant has or may have under the Plan shall be suspended automatically during the pendency of
any investigation by the Administrator or its designee, or during any negotiations between the Administrator or its designee and the Participant,
regarding any actual or alleged act or omission by the Participant of the type described in the applicable definition of Cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Section
1.10 &ldquo;<B><U>Change in Control</U></B>&rdquo; means the first to occur of any of the following events after the Effective Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(a)&nbsp;any Person
becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 30% or more of either (x) the then-outstanding
shares of common stock of the Company (the &ldquo;<B><U>Outstanding Company Common Stock</U></B>&rdquo;) or (y) the combined voting power
of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (the &ldquo;<B><U>Outstanding
Company Voting Securities</U></B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(b)&nbsp;the individuals
who constitute the Board as of the Effective Date (the &ldquo;<B><U>Incumbent Board</U></B>&rdquo;) cease for any reason to constitute
at least a majority of the Board;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that any individual becoming a Director subsequent to the
Effective Date whose election, or nomination for election, by the Company&rsquo;s stockholders, was approved by a vote of at least a majority
of the Directors then comprising the Incumbent Board shall be considered as though such individual was a member of the Incumbent Board,
but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened
election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents
by or on behalf of a Person other than the Board; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 2 of 17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(c)&nbsp;the consummation
of a reorganization, merger, statutory share exchange or consolidation or similar transaction involving the Company or any of its Subsidiaries,
a sale or other disposition of all or substantially all of the assets of the Company, or the acquisition of assets or stock of another
entity by the Company or any of its Subsidiaries (each, a &ldquo;<B><U>Business Combination</U></B>&rdquo;), in each case, unless, following
such Business Combination, (i) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding
Company Common Stock and the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly
or indirectly, more than 50% of the then-outstanding shares of common stock (or, for a non-corporate entity, equivalent securities) and
the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of Directors (or, for a
non-corporate entity, equivalent governing body), as the case may be, of the entity resulting from such Business Combination (including,
without limitation, an entity that, as a result of such transaction, owns the Company or all or substantially all of the Company&rsquo;s
assets either directly or through one or more Subsidiaries) in substantially the same proportions as their ownership immediately prior
to such Business Combination of the Outstanding Company Common Stock and the Outstanding Company Voting Securities, as the case may be,
(ii) no Person (excluding any corporation resulting from such Business Combination or any employee benefit plan (or related trust) of
the Company or such corporation resulting from such Business Combination) beneficially owns, directly or indirectly, 30% or more of, respectively,
the then-outstanding shares of common stock (or, for a non-corporate entity, equivalent securities) of the entity resulting from such
Business Combination or the combined voting power of the then-outstanding voting securities of such entity entitled to vote generally
in the election of directors (or, for a non-corporate entity, equivalent securities), except to the extent that such ownership existed
prior to the Business Combination, and (iii) at least a majority of the members of the board of directors (or, for a non-corporate entity,
equivalent governing body) of the entity resulting from such Business Combination were members of the Incumbent Board at the time of the
execution of the initial agreement or of the action of the Board providing for such Business Combination;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">in each case,&nbsp;<U>provided</U>&nbsp;that,
as to Awards subject to Section 409A of the Code, the payment or settlement of which will occur by reason of the Change in Control, such
event also constitutes a &ldquo;change in control&rdquo; within the meaning of Section 409A of the Code. In addition, notwithstanding
the foregoing, a &ldquo;Change in Control&rdquo; shall not be deemed to occur if the Company files for bankruptcy, liquidation or reorganization
under the United States Bankruptcy Code or as a result of any restructuring that occurs as a result of any such proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.11 &ldquo;<B><U>Change
in Control Price</U></B>&rdquo; means the price per share of Company Common Stock paid in conjunction with any transaction resulting in
a Change in Control. If any part of the offered price is payable other than in cash, the value of the non-cash portion of the Change in
Control Price shall be determined in good faith by the Administrator as constituted immediately prior to the Change in Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.12 &ldquo;<B><U>Code</U></B>&rdquo;
means the Internal Revenue Code of 1986, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.13 &ldquo;<B><U>Company
Common Stock</U></B>&rdquo; means the common stock, par value $0.0001 per share, of the Company and such other stock or securities into
which such common stock is hereafter converted or for which such common stock is exchanged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.14 &ldquo;<B><U>Company
Group</U></B>&rdquo; means the Company and its direct or indirect Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.15 &ldquo;<B><U>Compensation
Year</U></B>&rdquo; means the period from one annual meeting of stockholders to the next following annual meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.16 &ldquo;<B><U>Competitive
Activity</U></B>&rdquo; means a Participant&rsquo;s material breach of restrictive covenants relating to noncompetition, nonsolicitation
(of customers or employees) or preservation of confidential information or other covenants having the same or similar scope, included
in an Award Agreement or other agreement to which the Participant and the Company or any of its Affiliates is a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.17 &ldquo;<B><U>Corporate
Event</U></B>&rdquo; means, as determined by the Administrator, any transaction or event described in Section 3.3(a) or any unusual or
infrequently occurring transaction or event affecting the Company, any Subsidiary of the Company, or the financial statements of the Company
or any of its Subsidiaries, or changes in applicable laws, regulations or accounting principles (including, without limitation, a recapitalization
of the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.18 &ldquo;<B><U>Director</U></B>&rdquo;
means a member of the Board or a member of the board of directors of any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 3 of 17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.19 &ldquo;<B><U>Disability</U></B>&rdquo;
means (x) for Awards that are not subject to Section 409A of the Code, &ldquo;disability&rdquo; as such term is defined in the long-term
disability insurance plan or program of the Company or any Subsidiary then covering the Participant, and (y) for Awards that are subject
to Section 409A of the Code, &ldquo;disability&rdquo; has the meaning set forth in Section 409A(a)(2)(c) of the Code;&nbsp;<U>provided</U>&nbsp;that
with respect to Awards that are not subject to Section 409A, in the case of any Participant who, as of the date of determination, is a
party to an effective services, severance, consulting or employment agreement with the Company or any Subsidiary of the Company that employs
such individual, &ldquo;Disability&rdquo; has the meaning, if any, specified in such agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.20 &ldquo;<B><U>Dividend
Equivalent</U></B>&rdquo; means the right to receive payments, in cash or in Shares, based on dividends paid with respect to Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.21 &ldquo;<B><U>Eligible
Representative</U></B>&rdquo; for a Participant means such Participant&rsquo;s personal representative or such other person as is empowered
under the deceased Participant&rsquo;s will or the then applicable laws of descent and distribution to represent the Participant hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.22 &ldquo;<B><U>Employee</U></B>&rdquo;
means any individual classified as an employee by the Company or one of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.23 &ldquo;<B><U>Exchange
Act</U></B>&rdquo; means the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.24 &ldquo;<B><U>Executive
Officer</U></B>&rdquo; means each person who is an officer or employee of the Company or any of its Subsidiaries and who is subject to
the reporting requirements under Section 16(a) of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.25 &ldquo;<B><U>Fair
Market Value</U></B>&rdquo; means, unless otherwise determined by the Administrator from time to time, the closing transaction price of
a Share as reported on the NASDAQ Stock Market LLC on the date as of which such value is being determined or, if Shares are not listed
on the NASDAQ Stock Market LLC, the closing transaction price of a Share on the principal national stock exchange on which Shares are
traded on the date as of which such value is being determined or, if there shall be no reported transactions for such date, on the next
preceding date for which transactions were reported; provided, however, that if Shares are not listed on a national stock exchange or
if Fair Market Value for any date cannot be so determined, Fair Market Value shall be determined by the Administrator by whatever means
or method as the Administrator, in the good faith exercise of its discretion, shall at such time deem appropriate and in compliance with
Section 409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.26 &ldquo;<B><U>Good
Reason</U></B>&rdquo; means, unless otherwise provided in the Award Agreement, a material reduction in the Participant&rsquo;s base salary
or a material reduction in the Participant&rsquo;s target annual cash incentive compensation opportunity, in each case, other than (a)
any isolated or inadvertent failure by the Company or the applicable Subsidiary that is not in bad faith and is cured within thirty (30)
business days after the Participant gives the Company or the applicable Subsidiary notice of such event or (b) a reduction of 10% or less
which is applicable to all employees in the same salary grade as the Participant;&nbsp;<U>provided</U>&nbsp;that in the case of any Participant
who, as of the date of determination, is a party to an effective services, severance, consulting or employment agreement with the Company
or any Subsidiary of the Company that employs such individual, &ldquo;Good Reason&rdquo; has the meaning, if any, specified in such agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.27 &ldquo;<B><U>Incentive
Stock Option</U></B>&rdquo; means an Option which qualifies under Section 422 of the Code and is expressly designated as an Incentive
Stock Option in the Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.28 &ldquo;<B><U>Non-Qualified
Stock Option</U></B>&rdquo; means an Option that is not an Incentive Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.29 &ldquo;<B><U>Option</U></B>&rdquo;
means an option to purchase Company Common Stock granted under the Plan. The term &ldquo;Option&rdquo; includes both an Incentive Stock
Option and a Non-Qualified Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.30 &ldquo;<B><U>Participant</U></B>&rdquo;
means any Service Provider who has been granted an Award pursuant to the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 4 of 17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.31 &ldquo;<B><U>Performance
Award</U></B>&rdquo; means a Performance Shares or a Performance Unit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.32 &ldquo;<B><U>Performance
Cycle</U></B>&rdquo; means the period of time selected by the Administrator during which performance is measured for the purpose of determining
the extent to which a Performance Award has been earned or vested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.33 &ldquo;<B><U>Performance
Goals</U></B>&rdquo; means the objectives established by the Administrator for a Performance Cycle pursuant to Section 6.5 for the purpose
of determining the extent to which a Performance Award has been earned or vested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.34 &ldquo;<B><U>Performance
Share</U></B>&rdquo; means an Award granted pursuant to Article VI of the Plan of a Share or a contractual right to receive a Share (or
the cash equivalent thereof) upon the achievement, in whole or in part, of the applicable Performance Goals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.35 &ldquo;<B><U>Performance
Unit</U></B>&rdquo; means a U.S. Dollar-denominated unit (or a unit denominated in the Participant&rsquo;s local currency) granted pursuant
to Article VI of the Plan, payable in cash or in Shares upon the achievement, in whole or in part, of the applicable Performance Goals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.36 &ldquo;<B><U>Person</U></B>&rdquo;
means an individual, partnership, corporation, limited liability company, business trust, joint stock company, trust, unincorporated association,
joint venture, governmental authority or any other entity of whatever nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.37 &ldquo;<B><U>Replacement
Awards</U></B>&rdquo; means Shares or Awards issued in assumption of, or in substitution for, any outstanding awards of any entity acquired
in any form or combination by the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.38 &ldquo;<B><U>Restricted
Stock</U></B>&rdquo; means an Award granted pursuant to Section 5.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.39 &ldquo;<B><U>Restricted
Stock Unit</U></B>&rdquo; means an Award granted pursuant to Section 5.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.40 &ldquo;<B><U>Securities
Act</U></B>&rdquo; means the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.41 &ldquo;<B><U>Service
Provider</U></B>&rdquo; means an Employee, Director or consultant of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.42 &ldquo;<B><U>Share</U></B>&rdquo;
means a share of Company Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.43 &ldquo;<B><U>Stock
Appreciation Right</U></B>&rdquo; or &ldquo;<B><U>SAR</U></B>&rdquo; means the right to receive a payment from the Company in cash and/or
Shares equal to the excess, if any, of the Fair Market Value of one Share on the exercise date over a specified price (the &ldquo;<B><U>Base
Price</U></B>&rdquo;) fixed by the Administrator on the grant date (which specified price shall not be less than the Fair Market Value
of one Share on the grant date).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.44 &ldquo;<B><U>Subsidiary</U></B>&rdquo;
means any entity that is directly or indirectly controlled by the Company or any entity in which the Company directly or indirectly has
at least a 50% equity interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.45 &ldquo;<B><U>Termination
of employment</U></B>,&rdquo; &ldquo;<B><U>termination of service</U></B>&rdquo; and any similar term or terms means, with respect to
a Director who is not an Employee of the Company or any Subsidiary, the date upon which such Director ceases to be a member of the Board
or of the board of directors of any Subsidiary, with respect to a consultant of the Company or any of its Subsidiaries, the date upon
which such consultant ceases to provide services to the Company and its Subsidiaries and, with respect to an Employee, the date he or
she ceases to be an Employee;&nbsp;<U>provided</U>&nbsp;that with respect to any Award subject to Section 409A of the Code, such terms
shall mean &ldquo;separation from service,&rdquo; as defined in Section 409A of the Code and the rules, regulations and guidance promulgated
thereunder. Unless otherwise determined by the Administrator, a &ldquo;termination of employment&rdquo; or &ldquo;termination of service&rdquo;
shall not occur if an Employee, consultant or Director, immediately upon ceasing to provide services in such capacity, commences to or
continues to provide services to the Company or any of its Affiliates in another of such capacities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 5 of 17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Article II<BR>
<U>ADMINISTRATION</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.1&nbsp;<U>Powers
of the Administrator</U>. The Plan shall be administered by the Administrator. The Administrator shall have the sole and complete authority
and discretion to: (i) determine the type or types of Awards to be granted to each Participant; (ii) select the Service Providers to whom
Awards may from time to time be granted; (iii) determine all matters and questions related to the termination of service of a Service
Provider with respect to any Award granted to him or her; (iv) determine the number of Awards to be granted and the number of Shares to
which an Award will relate; (v) approve forms of agreement for use under the Plan, which need not be identical for each Service Provider;
(vi) determine the terms and conditions of any Awards (including, without limitation, the exercise price, the time or times when Awards
may be exercised (which may be based on performance criteria), any vesting acceleration or waiver of forfeiture restrictions and any restriction
or limitation regarding any Award or the Company Common Stock relating thereto) based in each case on such factors as the Administrator
shall determine; (vii) prescribe, amend and rescind rules and regulations relating to the Plan, including rules and regulations relating
to Subplans (as defined in Section 2.4) established for the purpose of satisfying applicable foreign laws; (viii) determine whether, to
what extent, and pursuant to what circumstances an Award may be settled in, or the exercise or purchase price of an Award may be paid
in, cash, Company Common Stock, other Awards, or other property, or an Award may be canceled, forfeited or surrendered; (ix) suspend or
accelerate the vesting of any Award granted under the Plan or waive the forfeiture restrictions or any other restriction or limitation
regarding any Awards or the Company Common Stock relating thereto; (x) construe and interpret the terms of the Plan and Awards granted
pursuant to the Plan; and (xi) make all other decisions and determinations that may be required pursuant to the Plan or as the Administrator
deems necessary or advisable to administer the Plan. Any determination made by the Administrator under the Plan, including, without limitation,
under Section 3.3, shall be final, binding and conclusive on all Participants and other persons having or claiming any right or interest
under the Plan. The Administrator&rsquo;s determinations under the Plan need not be uniform and may be made by the Administrator selectively
among persons who receive, or are eligible to receive, Awards under the Plan, whether or not such persons are similarly situated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.2&nbsp;<U>Delegation
by the Administrator</U>. The Administrator may delegate, subject to such terms or conditions or guidelines as it shall determine, to
any officer or group of officers, or Director or group of Directors of the Company or its Subsidiaries any portion of its authority and
powers under the Plan with respect to Participants who are not Executive Officers or non-employee directors of the Board;&nbsp;<U>provided</U>&nbsp;that
any delegation to one or more officers of the Company shall be subject to and comply with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.3&nbsp;<U>Expenses,
Professional Assistance, No Liability</U>. All expenses and liabilities incurred by the Administrator in connection with the administration
of the Plan shall be borne by the Company. The Administrator may elect to engage the services of attorneys, consultants, accountants or
other persons. The Administrator, the Company and its officers and Directors shall be entitled to rely upon the advice, opinions or valuations
of any such persons. The Administrator (and its members) shall not be personally liable for any action, determination or interpretation
made with respect to the Plan or the Awards, and the Administrator (and its members) shall be fully protected by the Company with respect
to any such action, determination or interpretation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.4&nbsp;<U>Participants
Based Outside the United States</U>. To conform with the provisions of local laws and regulations, or with local compensation practices
and policies, in foreign countries in which the Company or any of its Subsidiaries operate, but subject to the limitations set forth herein
regarding the maximum number of shares issuable hereunder and the maximum award to any single Participant, the Administrator may (i) modify
the terms and conditions of Awards granted to Employees employed and consultants who provide services outside the United States (&ldquo;<B><U>Non-U.S.
Awards</U></B>&rdquo;), (ii) establish subplans with such modifications as may be necessary or advisable under the circumstances (&ldquo;<B><U>Subplans</U></B>&rdquo;)
and (iii) take any action which it deems advisable to obtain, comply with or otherwise reflect any necessary governmental regulatory procedures,
exemptions or approvals with respect to the Plan. The Administrator&rsquo;s decision to grant Non-U.S. Awards or to establish Subplans
is entirely voluntary, and at the complete discretion of the Administrator. The Administrator may amend, modify or terminate any Subplans
at any time, and such amendment, modification or termination may be made without prior notice to the Participants. The Company, Affiliates
and members of the Administrator shall not incur any liability of any kind to any Participant as a result of any change, amendment or
termination of any Subplan at any time. The benefits and rights provided under any Subplan or by any Non-U.S. Award (x) are wholly discretionary
and, although provided by either the Company or an Affiliate of the Company, do not constitute regular or periodic payments and (y) except
as otherwise required under applicable laws, are not to be considered part of the Participant&rsquo;s salary or compensation under the
Participant&rsquo;s employment with the Participant&rsquo;s local employer for purposes of calculating any severance, resignation, redundancy
or other end of service payments, vacation, bonuses, long-term service awards, indemnification, pension or retirement benefits, or any
other payments, benefits or rights of any kind. If a Subplan is terminated, the Administrator may direct the payment of Non-U.S. Awards
(or direct the deferral of payments whose amount shall be determined) prior to the dates on which payments would otherwise have been made,
and determine if such payments may be made in a lump sum or in installments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 6 of 17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Article III<BR>
<U>SHARES SUBJECT TO PLAN</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.1&nbsp;<U>Shares
Subject to Plan</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(a)&nbsp;Subject to
Section 3.3 and Section 3.6, the aggregate number of Shares which may be issued under this Plan shall be 4,249,933 (the <B><U>&ldquo;Share
Limit</U></B>&rdquo;). All of the Shares reserved under the Plan may be issued in the form of Incentive Stock Options under the Plan,
subject to the limitation set forth in Section 3.6. The Shares issued under the Plan may be authorized but unissued, or reacquired Company
Common Stock. No provision of this Plan shall be construed to require the Company to maintain the Shares in certificated form. Unless
the Administrator shall determine otherwise, (x) Awards may not consist of fractional shares and shall be rounded down to the nearest
whole Share, and (y) fractional Shares shall not be issued under the Plan (and shall instead also be rounded as aforesaid).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 37pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(b)&nbsp;If any Award
or portion thereof under this Plan is for any reason forfeited, canceled, cash-settled, expired or otherwise terminated without the issuance
of Shares, the Shares subject to such forfeited, canceled, cash-settled, expired or otherwise terminated Award, or portion thereof, shall
again be available for grant under the Plan. If Shares are tendered or withheld from issuance with respect to an Award by the Company
in satisfaction of any Exercise Price, Base Price or tax withholding or similar obligations, such tendered or withheld Shares shall again
be available for grant under the Plan. Notwithstanding the foregoing, and except to the extent required by applicable law, Replacement
Awards shall not be counted against Shares available for grant pursuant to this Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.2&nbsp;<U>Limitation
on Non-Employee Director Awards</U>. The maximum number of Shares subject to Awards granted during a single Compensation Year to any non-employee
Director, taken together with any cash fees paid during the Compensation Year to the non-employee Director, in respect of the Director&rsquo;s
service as a member of the Board during such year (including service as a member or chair of any committees of the Board), shall not exceed
(i) $500,000 in total value; or <FONT STYLE="background-color: white">(ii)&nbsp;in the event such&nbsp;</FONT>non-employee Director <FONT STYLE="background-color: white">is
first appointed or elected to the Board during such </FONT>Compensation Year<FONT STYLE="background-color: white">, $750,000 in total
value, or (iii) in the event such non-employee Director is serving as&nbsp;</FONT>non-employee Chairperson (or co-Chairperson) <FONT STYLE="background-color: white">of
the Board, $750,000 in total value, in each case calculating the value of any equity awards based on the grant date fair value of such
equity awards for financial reporting purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.3&nbsp;<U>Changes
in Company Common Stock; Disposition of Assets and Corporate Events</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(a)&nbsp;If and to
the extent necessary or appropriate to reflect any stock dividend, extraordinary dividend, stock split or share combination or any recapitalization,
merger, consolidation, exchange of shares, spin-off, liquidation or dissolution of the Company or other similar transaction affecting
the Company Common Stock (each, a &ldquo;<B><U>Corporate Event</U></B>&rdquo;), the Administrator shall adjust the number of shares of
Company Common Stock available for issuance under the Plan, the ISO Limit, and the number, class and Exercise Price (if applicable) or
Base Price (if applicable) of any outstanding Award, and/or make such substitution, revision or other provisions or take such other actions
with respect to any outstanding Award or the holder or holders thereof, in each case as it determines to be equitable. Without limiting
the generality of the foregoing sentence, in the event of any such Corporate Event, the Administrator shall have the power to make such
changes as it deems appropriate in (i) the number and type of shares or other securities covered by outstanding Awards, (ii) the prices
specified therein (if applicable), (iii) the securities, cash or other property to be received upon the exercise, settlement or conversion
of such outstanding Awards or otherwise to be received in connection with such outstanding Awards and (iv) any applicable Performance
Goals. After any adjustment made by the Administrator pursuant to this Section 3.3, the number of shares subject to each outstanding Award
shall be rounded down to the nearest whole number of whole or fractional shares (as determined by the Administrator), and (if applicable)
the Exercise Price or Base Price thereof shall be rounded up to the nearest cent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 7 of 17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(b)&nbsp;Any adjustment
of an Award pursuant to this Section 3.3 shall be effected in compliance with Section 424 and 409A of the Code to the extent applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.4&nbsp;<U>Award
Agreement Provisions</U>. The Administrator may include such provisions and limitations in any Award Agreement as it shall determine,
subject to the terms of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.5&nbsp;<U>Prohibition
Against Repricing</U>. Except to the extent (i) approved in advance by the stockholders of the Company or (ii) pursuant to Section 3.3
as a result of any Corporate Event or pursuant to Article XI in connection with a Change in Control, the Administrator shall not have
the power or authority to reduce, whether through amendment or otherwise, the Exercise Price of any outstanding Option or Base Price or
any outstanding SAR or to grant any new Award, or make any cash payment, in substitution for or upon the cancellation of Options or SARs
previously granted and as to which the Exercise Price or Base Price thereof is in excess of the then-current Fair Market Value of Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.6 <U>Maximum Number
of Incentive Stock Options</U>. Notwithstanding the Share Limit, and subject to adjustment in accordance with Section 3.3 hereof, the
maximum number of Shares that may be granted in connection with, and issued pursuant to the exercise of, Incentive Stock Options granted
under this Plan is 4,249,933 shares (the &ldquo;<B><U>ISO Limit</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Article IV<BR>
<U>OPTIONS AND SARS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.1&nbsp;<U>Grant
of Options and SARs</U>. The Administrator is authorized to make Awards of Options and/or SARs to any Service Provider in such amounts
and subject to such terms and conditions as determined by the Administrator, consistent with the Plan. SARs may be granted in tandem with
Options or may be granted on a freestanding basis, not related to any Option. Excluding Replacement Awards, the per Share purchase price
of the Shares subject to each Option (the &ldquo;<B><U>Exercise Price</U></B>&rdquo;) and the Base Price of each SAR shall be not less
than 100% of the Fair Market Value of a Share on the date such Option or SAR is granted. Each Option and each SAR shall be evidenced by
an Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.2&nbsp;<U>Exercisability
and Vesting; Exercise</U>. Each Option and SAR shall vest and become exercisable according to the terms and conditions as determined by
the Administrator. Except as otherwise determined by the Administrator, SARs granted in tandem with an Option shall become vested and
exercisable on the same date or dates as the Options with which such SARs are associated vest and become exercisable. SARs that are granted
in tandem with an Option may only be exercised upon the surrender of the right to exercise such Option for an equivalent number of Shares,
and may be exercised only with respect to the Shares for which the related Option is then exercisable. The Administrator shall specify
the manner of and any terms and conditions of exercise of an exercisable Option or SAR, including but not limited to net-settlement, delivery
of previously owned stock and broker-assisted sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.3&nbsp;<U>Settlement
of SARs</U>. Upon exercise of a SAR, the Participant shall be entitled to receive payment in Shares, or such other form as determined
by the Administrator, having an aggregate value equal to the Fair Market Value of one Share on the exercise date over (ii) the Base Price
of such SAR;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that on the grant date, the Administrator may establish a maximum amount per Share
that may be payable upon exercise of a SAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.4&nbsp;<U>Expiration
of Options and SARs</U>. No Option or SAR may be exercised after the expiration of ten (10) years from the date the Option or SAR was
granted, unless a longer or shorter period is set forth in the Award Agreement. Notwithstanding the foregoing, in the event that on the
last business day of the term of the Option or SAR (x) the exercise of the Option or SAR is prohibited by applicable law or (y) Shares
may not be purchased or sold by certain employees or directors of the Company due to the &ldquo;black-out period&rdquo; of a Company policy
or a &ldquo;lock-up&rdquo; agreement undertaken in connection with an issuance of securities by the Company, the term of the Option or
SAR shall be extended but not beyond a period of thirty (30) days following the end of the legal prohibition, black-out period or lock-up
agreement (to the extent permissible under Section 409A of the Code) and provided further that no extension will be made if the applicable
Exercise Price or Base Price at the date the initial term would otherwise expire is below the Fair Market Value on such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 8 of 17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Article V<U><BR>
Restricted Stock Awards AND RESTRICTED STOCK UNIT AWARDS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 5.1&nbsp;<U>Restricted
Stock</U>. The Administrator is authorized to make Awards of Restricted Stock to any Service Provider selected by the Administrator in
such amounts and subject to such terms and conditions as determined by the Administrator. All Awards of Restricted Stock shall be evidenced
by an Award Agreement. Restricted Stock shall be subject to such restrictions on transferability and other restrictions as the Administrator
may impose. These restrictions may lapse separately or in combination at such times, pursuant to such circumstances, in such installments,
or otherwise, as the Administrator determines at the time of the grant of the Award or thereafter. The issuance of Restricted Stock granted
pursuant to the Plan may be evidenced in such manner as the Administrator shall determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 5.2&nbsp;<U>Restricted
Stock Units</U>. The Administrator is authorized to make Awards of Restricted Stock Units to any Service Provider selected by the Administrator
in such amounts and subject to such terms and conditions as determined by the Administrator. The Administrator may specify any conditions
to vesting as it deems appropriate. For the avoidance of doubt, the Administrator may grant Restricted Stock Units that are fully vested
and nonforfeitable when granted. At the time of grant, the Administrator shall specify the settlement date applicable to each grant of
Restricted Stock Units. Unless otherwise provided in an Award Agreement, on the settlement date, the Company shall, subject to the terms
of this Plan, transfer to the Participant one Share (or a cash amount equal to the then Fair Market Value of a Share) for each Restricted
Stock Unit scheduled to be paid out on such date and not previously forfeited. A Participant shall not be, nor have any of the rights
or privileges of, a stockholder in respect of Restricted Stock Units awarded pursuant to the Plan unless and until the Shares attributable
to such Restricted Stock Units have been issued to such Participant. Notwithstanding the foregoing, unless otherwise determined by the
Administrator, the Restricted Stock Units awarded pursuant to the Plan will receive Dividend Equivalents in accordance with Article VIII.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Article VI<BR>
<U>Performance AWARDS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.1&nbsp;<U>Grant
of Performance Awards</U>. The Administrator is authorized to make Performance Awards to any Participant selected by the Administrator
in such amounts and subject to such terms and conditions as determined by the Administrator. All Performance Shares and Performance Units
shall be evidenced by an Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.2&nbsp;<U>Issuance
and Restrictions</U>. The Administrator shall have the authority to determine the Participants who shall receive Performance Awards; the
number of Performance Shares, the number and value of Performance Units; the cash entitlement of any Participant with respect to any Performance
Cycle; and the Performance Goals applicable in respect of such Performance Awards for each Performance Cycle. The Administrator shall
determine the duration of each Performance Cycle (the duration of Performance Cycles may differ from one another), and there may be more
than one Performance Cycle in existence at any one time. An Award Agreement evidencing the grant of Performance Shares or Performance
Units shall specify the number of Performance Shares and the number and value of Performance Units awarded to the Participant, the Performance
Goals applicable thereto, and such other terms and conditions as the Administrator shall determine. Unless the Administrator shall determine
otherwise, no Company Common Stock will be issued at the time an Award of Performance Shares is made. The Company shall not be required
to set aside a fund for the payment of Performance Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 9 of 17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.3&nbsp;<U>Earned
Performance Awards</U>. Performance Awards shall become earned, in whole or in part, based upon the attainment of specified Performance
Goals or the occurrence of any event or events, as the Administrator shall determine or as set forth in an Award Agreement. In addition
to the achievement of the specified Performance Goals, the Administrator may condition payment of Performance Awards on such other conditions
as the Administrator shall determine. The Administrator may also provide in an Award Agreement for the completion of a minimum period
of service (in addition to the achievement of any applicable Performance Goals) as a condition to the vesting of any Performance Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.4&nbsp;<U>Rights
as a Stockholder</U>. A Participant shall not have any rights as a stockholder in respect of Performance Awards (including, without limitation,
the right to vote on any matter submitted to the Company&rsquo;s stockholders) until such time as the Shares attributable to such Performance
Awards have been issued to such Participant or his or her beneficiary. Performance Shares as to which Shares are issued prior to the end
of the Performance Cycle shall, during such period, be subject to such restrictions on transferability and other restrictions as the Administrator
may impose. Notwithstanding the foregoing, unless otherwise determined by the Administrator, the Performance Awards awarded pursuant to
the Plan will receive Dividend Equivalents settled in Shares in accordance with Article VIII.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.5&nbsp;<U>Performance
Goals and Related Provisions</U>. The Administrator shall establish the Performance Goals that must be satisfied in order for a Participant
to receive an Award for a Performance Cycle or for a Performance Award to be earned or vested. The Administrator may provide for a threshold
level of performance below which no amount of compensation will be paid and a maximum level of performance above which no additional amount
of compensation will be paid under the Plan, and it may provide for the payment of differing amounts of compensation for different levels
of performance. Performance Goals may be established on a Company-wide basis, with respect to one or more business units, divisions, Subsidiaries
or products or based on individual performance measures, and may be expressed in absolute terms or relative to other metrics including
internal targets or budgets, past performance of the Company, the performance of one or more similarly situated companies, performance
of an index, outstanding equity or other external measures. In the case of earning-based measures, performance goals may include comparisons
relating to capital (including but limited to, the cost of capital), stockholders&rsquo; equity, shares outstanding, assets or net assets,
or any combination thereof. Performance Goals may also be subject to such other terms and conditions as the Administrator may determine
appropriate. The Administrator may also adjust the Performance Goals for any Performance Cycle as it deems equitable in recognition of
unusual or non-recurring events affecting the Company; changes in applicable tax laws or accounting principles; other extraordinary events
such as restructurings; discontinued operations; asset write-downs; significant litigation or claims, judgments or settlements; acquisitions
or divestitures; reorganizations or changes in the corporate structure or capital structure of the Company; foreign exchange gains and
losses; change in the fiscal year of the Company; business interruption events; unbudgeted capital expenditures; unrealized investment
gains and losses; impairments and/or such other factors as the Administrator may determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.6&nbsp;<U>Determination
of Attainment of Performance Goals</U>. As soon as practicable following the end of a Performance Cycle and prior to any payment or vesting
in respect of such Performance Cycle, the Administrator shall determine the number of Performance Shares or other Performance Awards and
the number and value of Performance Units or the amount of any cash entitlement, in each case that has been earned or vested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.7&nbsp;<U>Payment
of Awards</U>. Payment or delivery of Company Common Stock with respect to earned Performance Shares, earned Performance Units and earned
cash entitlements shall be made to the Participant or, if the Participant has died, to the Participant&rsquo;s Eligible Representative,
as soon as practicable after the expiration of the Performance Cycle and the Administrator&rsquo;s determination under Section 6.6 above
and (unless an applicable Award Agreement shall set forth one or more other dates) in any event no later than the earlier of (i) ninety
(90) days after the end of the fiscal year in which the Performance Cycle has ended and (ii) ninety (90) days after the expiration of
the Performance Cycle. The Administrator shall determine and set forth in the applicable Award Agreement whether earned Performance Shares
and the value of earned Performance Units are to be distributed in the form of cash, Shares or in a combination thereof, with the value
or number of Shares payable to be determined based on the Fair Market Value of the Company Common Stock on the date of the Administrator&rsquo;s
determination under Section 6.6 above or such other date specified in the Award Agreement. The Administrator may, in an Award Agreement
with respect to the Award or delivery of Shares, condition the vesting of such Shares on the performance of additional service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.8&nbsp;<U>Newly
Eligible Participants</U>. Notwithstanding anything in this Article VI to the contrary, the Administrator shall be entitled to make such
rules, determinations and adjustments as it deems appropriate with respect to any Participant who becomes eligible to receive Performance
Shares, Performance Units or other Performance Awards after the commencement of a Performance Cycle.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 10 of 17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Article VII<BR>
<U>OTHER Stock-Based Awards</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 7.1 <U>Grant of Stock-Based
Awards</U>. The Administrator is authorized to make Awards of other types of equity-based or equity-related awards and fully vested stock
awards, including grants of fully vested Shares (collectively, &ldquo;<B><U>Stock-Based Awards</U></B>&rdquo;) not otherwise described
by the terms of the Plan in such amounts and subject to such terms and conditions as the Administrator shall determine, including without
limitation the payment of cash bonuses or other incentives in the form of Stock-Based Awards. Unless otherwise determined by the Administrator,
all Stock-Based Awards shall be evidenced by an Award Agreement. Such Stock-Based Awards may be granted as an inducement to enter the
employ of the Company, any Affiliate or any Subsidiary or in satisfaction of any obligation of the Company, any Affiliate or any Subsidiary
to an officer or other key employee, whether pursuant to this Plan or otherwise, that would otherwise have been payable in cash or in
respect of any other obligation of the Company. Such Stock-Based Awards may entail the transfer of actual Shares, or payment in cash or
otherwise of amounts based on the value of Shares and may include, without limitation, Awards designed to comply with or take advantage
of the applicable local laws of jurisdictions other than the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Article VIII<BR>
<U>Dividend Equivalents</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 8.1&nbsp;<U>Generally</U>.
Dividend Equivalents may be granted to Participants at such time or times as shall be determined by the Administrator. Dividend Equivalents
may be granted in tandem with other Awards, in addition to other Awards, or freestanding and unrelated to other Awards. Notwithstanding
the terms of this Section 8.1, no Dividend Equivalents shall be granted with respect to Options or SARs. The grant date of any Dividend
Equivalents will be the date on which the Dividend Equivalent is awarded by the Administrator, or such other date permitted by applicable
laws as the Administrator shall determine. Dividend Equivalents may, at the discretion of the Administrator, be fully vested and nonforfeitable
when granted or subject to such vesting conditions as determined by the Administrator;&nbsp;<U>provided</U>, that, unless the Administrator
shall determine otherwise in an Award Agreement, Dividend Equivalents with respect to Awards shall not be fully vested until the Awards
have been earned and shall be forfeited if the related Award is forfeited. Dividend Equivalents shall be evidenced in writing, whether
as part of the Award Agreement governing the terms of the Award, if any, to which such Dividend Equivalent relates, or pursuant to a separate
Award Agreement with respect to freestanding Dividend Equivalents, in each case, containing such provisions not inconsistent with the
Plan as the Administrator shall determine, including customary representations, warranties and covenants with respect to securities law
matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Article IX<BR>
<U>Termination and Forfeiture</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.1&nbsp;<U>Termination
for Cause; Post-Service Competitive Activity</U>. Unless otherwise set forth in the Award Agreement, if a Participant&rsquo;s employment
or service terminates for Cause or a Participant engages in Competitive Activity following the Participant&rsquo;s termination of employment
or service, all Options and SARs, whether vested or unvested, and all other Awards that are unvested or unexercisable or otherwise unpaid
(or were unvested or unexercisable or unpaid at the time of occurrence of Cause or engagement in Competitive Activity) shall be immediately
forfeited and canceled, effective as of the date of the termination or engagement in Competitive Activity. If the Participant engages
in Competitive Activity following the termination, any portion of the Participant&rsquo;s Awards that became vested after termination,
and any Shares or cash issued upon exercise or settlement of such Awards, shall be immediately forfeited, canceled, and disgorged or paid
to the Company together with all gains earned or accrued due to the sale of Shares issued upon exercise or settlement of such Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 11 of 17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.2&nbsp;<U>Termination
due to Death</U>. Unless otherwise set forth in the Award Agreement, if a Participant&rsquo;s employment or service terminates by reason
of death:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 33pt">(a)&nbsp;All Options
and SARs (whether or not then otherwise exercisable) shall become exercisable in full and the Participant&rsquo;s Eligible Representative
may exercise all such Options and SARs at any time prior to the earlier of (i) the one-year anniversary of the Participant&rsquo;s death
or (ii) the expiration of the term of the Options or SARs;&nbsp;<U>provided</U>&nbsp;that any in-the-money Options and SARs that are still
outstanding on the last day of the time period specified in this Section 9.2(a) shall automatically be exercised on such date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 33pt">(b)&nbsp;All other
Awards shall immediately vest in full upon the Participant&rsquo;s death, and Restricted Stock Units and Performance Awards that have
not been settled or converted into Shares prior to the Participant&rsquo;s death shall immediately be settled in Shares. Any Performance
Awards that vest as a result of this Section 9.2(b) shall vest and be paid based on target levels of performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.3&nbsp;<U>Termination
due to Disability</U>. Unless otherwise set forth in the Award Agreement, if a Participant&rsquo;s employment or service terminates by
reason of Disability, the Participant shall be treated for purposes of the treatment of the Participant&rsquo;s Awards under this Section
9.3 as though the Participant continued in the employ or service of the Company and all unvested Awards shall remain outstanding and vest,
or in the case of Options and SARs, vest and become exercisable, in accordance with the terms set forth in the applicable Award Agreement.
Any Options or SARs granted to such Participant that are exercisable at the date of termination by reason of Disability or that thereafter
become exercisable by reason of the operation of the immediately preceding sentence may be exercised at any time prior to the earlier
of (i) the fifth anniversary of the Participant&rsquo;s termination for Disability or (ii) the expiration of the term of such Options
or SARs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.4&nbsp;<U>Involuntary
Termination Without Cause</U>. Unless otherwise set forth in the Award Agreement, if a Participant&rsquo;s employment or service is involuntarily
terminated without Cause:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(a)&nbsp;All Options
and SARs that are unvested shall be immediately forfeited and canceled, effective as of the date of the termination, and all Options and
SARs that are vested shall remain outstanding and exercisable until the earlier of (i) 30 days after the effective date of the termination
under this Section 9.4 or (ii) the expiration of the term of such Options or SARs; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(b)&nbsp;All Awards
of Restricted Stock or Restricted Stock Units that are unvested shall be immediately forfeited and canceled, effective as of the date
of the termination; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(c)&nbsp;Provided
that the Participant signs a general release and waiver of claims in the form provided by the Administrator and does not exercise any
rights to revoke such release, the Participant shall retain a portion of any unvested Performance Awards granted earlier than one year
prior to the termination under this Section 9.4 equal to, for each grant of Performance Awards, the number of Performance Shares or Performance
Units specified in the Award Agreement multiplied by the quotient of (i) the number of full months elapsed between the grant date in respect
of such Performance Awards and the effective date of the termination under this Section 9.4 over (ii) the total number of months in the
Performance Cycle. Such retained Performance Awards will remain outstanding and vest subject to the attainment of the applicable Performance
Goals in respect thereof. Any Performance Awards that do not vest pursuant to this Section 9.4(c) shall be immediately forfeited and canceled,
effective as of the date of the termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 12 of 17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.5&nbsp;<U>Termination
for Any Other Reason</U>. Unless otherwise set forth in the Award Agreement, if a Participant&rsquo;s employment or service terminates
for any reason other as set forth in Sections 9.1 (other than post-service Competitive Activity) through 9.4:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(a)&nbsp;All Options
and SARs that are unvested shall be immediately forfeited and canceled, effective as of the date of the termination, and all Options and
SARs that are vested shall remain outstanding and exercisable until the earlier of (i) 30 days after the effective date of the termination
under this Section 9.5 or (ii) the expiration of the term of such Options or SARs; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(b)&nbsp;All other
Awards that are unvested or have not otherwise been earned shall be immediately forfeited and canceled, effective as of the date of termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.6&nbsp;<U>Post-Termination
Informational Requirements</U>. Before the settlement of any Award following termination of employment or service, the Administrator may
require the Participant (or the Participant&rsquo;s Eligible Representative, if applicable) to make such representations and provide such
documents as the Administrator deems necessary or advisable to effect compliance with applicable law and the provisions of this Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.7&nbsp;<U>Forfeiture
and Recoupment of Awards</U>. Awards granted under this Plan (and gains earned or accrued in connection with Awards) shall be subject
to such generally applicable policies as to forfeiture and recoupment (including, without limitation, upon the occurrence of material
financial or accounting errors, financial or other misconduct or Competitive Activity) as may be adopted by the Administrator or the Board
from time to time. Any such policies may (in the discretion of the Administrator or the Board) be applied to outstanding Awards at the
time of adoption of such policies, or on a prospective basis only. Participants shall also forfeit and disgorge to the Company any Awards
granted or vested and any gains earned or accrued due to the exercise of Options or SARs or the sale of any Company Common Stock to the
extent required by applicable law or as required by any stock exchange or quotation system on which the Company Common Stock is listed
or quoted, in each case in effect on or after the Effective Date, including but not limited to Section 304 of the Sarbanes-Oxley Act of
2002 and Section 10D of the Exchange Act. The implementation of policies and procedures pursuant to this Section 9.7 and any modification
of the same shall not be subject to any restrictions on amendment or modification of Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.8&nbsp;<U>Clawbacks</U>.
Awards shall be subject to any generally applicable clawback policy adopted by the Administrator, the Board or the Company that is communicated
to the Participants or any such policy adopted to comply with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Article X<BR>
<U>CHANGE IN CONTROL</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 10.1&nbsp;<U>Alternative
Award</U>. Unless otherwise provided in an Award Agreement, and other than with respect to the Performance Award Conversion, no cancellation,
acceleration or other payment shall occur in connection with a Change in Control pursuant to Section 10.3 with respect to any Award or
portion thereof as a result of the Change in Control if the Administrator reasonably determines in good faith, prior to the occurrence
of the Change in Control, that such Award shall be honored or assumed, or new rights substituted therefor following the Change in Control
(such honored, assumed or substituted award, an &ldquo;<B><U>Alternative Award</U></B>&rdquo;),&nbsp;<U>provided</U>&nbsp;that any Alternative
Award must (i) give the Participant who held the Award rights and entitlements substantially equivalent to or better than the rights and
terms applicable under the Award immediately prior to the Change in Control, including an equal or better vesting schedule and that Alternative
Awards that are stock options have identical or better methods of payment of the exercise price thereof and a post-termination exercise
period extending until at least the fifth anniversary of the Participant&rsquo;s termination (or, if earlier, the expiration of the term
of such stock options); (ii) have terms such that if a Participant&rsquo;s employment is involuntarily (<I>i.e.</I>, by the Company or
its successor other than for Cause) or constructively (<I>i.e.</I>, by the Participant with Good Reason) terminated within the twenty-four
(24) months following a Change in Control at a time when any portion of the Alternative Award is unvested, the unvested portion of such
Alternative Award shall immediately vest in full and such Participant shall receive (as determined by the Board prior to the Change in
Control) either (1) a cash payment equal in value to the excess (if any) of the fair market value of the stock subject to the Alternative
Award at the date of exercise or settlement over the price (if any) that such Participant would be required to pay to exercise such Alternative
Award or (2) publicly-traded shares or equity interests equal in value (as determined by the Administrator) to the value in clause (1).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 13 of 17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 10.2&nbsp;<U>Performance
Award Conversion</U>. Unless otherwise provided in an Award Agreement, upon a Change in Control, then-outstanding Performance Awards shall
be modified to remove any Performance Goals applicable thereto and to substitute, in lieu of such Performance Goals, vesting solely based
on the requirement of continued service through, as nearly as is practicable, the date(s) on which the satisfaction of the Performance
Goals would have been measured if the Change in Control had not occurred (or, if applicable, the later period of required service following
such measurement date) (such Awards, the &ldquo;<B><U>Alternative Performance Awards</U></B>&rdquo;), with such service-vesting of the
Alternative Performance Awards to accelerate upon the termination of service of the holder prior to such vesting date(s) thereof, if such
termination of service satisfies the requirements of clause (ii) of Section 10.1 hereof. The number of Alternative Performance Awards
shall be equal to (i) if less than 50% of the Performance Cycle has elapsed, the target number of Performance Awards, and (ii) if 50%
or more of the Performance Cycle has elapsed, a number of Performance Awards based on actual performance through the date of the Change
in Control if determinable, or the target, if not determinable (with the Administrator as constituted prior to the Change in Control making
any determinations necessary to determine performance and the vesting date(s) thereof). The conversion of the Performance Awards into
Alternative Performance Awards is referred to herein as the &ldquo;<B><U>Performance Award Conversion</U></B>&rdquo;. Following the Performance
Award Conversion, the Alternative Performance Awards shall either remain outstanding as Alternative Awards consistent with this Section
10.2 or shall be treated as provided in Section 10.3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 10.3&nbsp;<U>Accelerated
Vesting and Payment</U>. Except as otherwise provided in this Article X or in an Award Agreement, upon a Change in Control:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(a)&nbsp;each vested
and unvested Option or SAR shall be canceled in exchange for a payment equal to the excess, if any, of the Change in Control Price over
the applicable Exercise Price or Base Price;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(b)&nbsp;the vesting
restrictions applicable to all other unvested Awards (other than (x) freestanding Dividend Equivalents not granted in connection with
another Award and (y) Performance Awards) shall lapse, all such Awards shall vest and become non-forfeitable and be canceled in exchange
for a payment equal to the Change in Control Price;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(c)&nbsp;the Alternative
Performance Awards shall be canceled in exchange for a payment equal to the Change in Control Price;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(d)&nbsp;all other
Awards (other than freestanding Dividend Equivalents not granted in connection with another Award) that were vested prior to the Change
in Control but that have not been settled or converted into Shares prior to the Change in Control shall be canceled in exchange for a
payment equal to the Change in Control Price; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(e)&nbsp;all freestanding
Dividend Equivalents not granted in connection with another Award shall be cancelled without payment therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent any portion of the Change in Control
Price is payable other than in cash and/or other than at the time of the Change in Control, Award holders under the Plan shall receive
the same value in respect of their Awards (less any applicable Exercise Price, Base Price or similar feature) as is received by the Company&rsquo;s
stockholders in respect of their Company Common Stock (as determined by the Administrator), and the Administrator shall determine the
extent to which such value shall be paid in cash, in securities or other property, or in a combination of cash and securities or other
property, consistent with applicable law. To the extent any portion of the Change in Control Price is payable other than at the time of
the Change in Control, the Administrator shall determine the time and form of payment to the Award holders consistent with Section 409A
of the Code and other applicable laws. Upon a Change in Control the Administrator may cancel Options and SARs for no consideration if
the Fair Market Value of the Shares subject to such Options or such SARs is less than or equal to the Exercise Price of such Options or
the Base Price of such SARs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 14 of 17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Article XI<BR>
<U>OTHER PROVISIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 11.1&nbsp;<U>Awards
Not Transferable</U>. Except as otherwise determined by the Administrator, no Award or interest or right therein or part thereof shall
be liable for the debts, contracts or engagements of the Participant or his or her successors in interest or shall be subject to disposition
by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary
or by operation of law, by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy),
and any attempted disposition thereof shall be null and void and of no effect;&nbsp;<U>provided, however</U>, that nothing in this Section
11.1 shall prevent transfers by will, by the applicable laws of descent and distribution or pursuant to the beneficiary designation procedures
approved by the Company pursuant to Section 11.13 or, with the prior approval of the Company, estate planning transfers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 11.2&nbsp;<U>Amendment,
Suspension or Termination of the Plan or Award Agreements</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(a)&nbsp;The Plan
may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Administrator;&nbsp;<U>provided</U>,
that without the approval of the stockholders of the Company, no amendment or modification to the Plan may (i) except as otherwise expressly
provided in Section 3.3, increase the number of Shares subject to the Plan; (ii) modify the class of persons eligible for participation
in the Plan or (iii) materially modify the Plan in any other way that would require stockholder approval under applicable law. Except
as otherwise expressly provided in the Plan, neither the amendment, suspension or termination of the Plan shall, without the written consent
of the holder of the Award, materially adversely alter or impair any rights or obligations under any Award theretofore granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(b)&nbsp;The Administrator
at any time, and from time to time, may amend the terms of any one or more existing Award Agreements,&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that the rights of a Participant under an Award Agreement shall not be materially adversely impaired without the Participant&rsquo;s written
consent. The Company shall provide a Participant with notice of any amendment made to a Participant&rsquo;s existing Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: 33pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">(c)&nbsp;No Award
may be granted during any period of suspension nor after termination of the Plan, and in no event may any Award be granted under this
Plan after the expiration of ten (10) years from the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 11.3&nbsp;<U>Effect
of Plan upon Other Award and Compensation Plans</U>. The adoption of this Plan shall not affect any other compensation or incentive plans
in effect for the Company or any of its Affiliates. Nothing in this Plan shall be construed to limit the right of the Company or any of
its Affiliates (a) to establish any other forms of incentives or compensation for Service Providers or (b) to grant or assume options
or restricted stock other than under this Plan in connection with any proper corporate purpose, including, but not by way of limitation,
the grant or assumption of options or restricted stock in connection with the acquisition by purchase, lease, merger, consolidation or
otherwise, of the business, stock or assets of any corporation, firm or association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 11.4&nbsp;<U>At-Will
Employment</U>. Nothing in the Plan or any Award Agreement hereunder shall confer upon the Participant any right to continue as a Service
Provider of the Company or any of its Affiliates or shall interfere with or restrict in any way the rights of the Company or any of its
Affiliates, which are hereby expressly reserved, to discharge any Participant at any time for any reason whatsoever, with or without Cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 11.5&nbsp;<U>Conformity
to Securities Laws</U>. The Plan is intended to conform to the extent necessary with all provisions of the Securities Act and the Exchange
Act and any and all regulations and rules promulgated under any of the foregoing, to the extent the Company, any of its Affiliates or
any Participant is subject to the provisions thereof. Notwithstanding anything herein to the contrary, the Plan shall be administered,
and Awards shall be granted and may be exercised, only in such a manner as to conform to such laws, rules and regulations. To the extent
permitted by applicable law, the Plan and Awards granted hereunder shall be deemed amended to the extent necessary to conform to such
laws, rules and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 15 of 17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 11.6&nbsp;<U>Term
of Plan</U>. The Plan was approved by the Board of Directors of the Company on April 26, 2022 (the &ldquo;<B><U>Adoption Date</U></B>&rdquo;),
subject to stockholder approval. The Plan shall be effective on the date of its approval by the stockholders of the Company at the 2022
annual meeting of stockholders (the &ldquo;<B><U>Effective Date</U></B>&rdquo;) in accordance with applicable law. No awards shall be
issued or granted under this Plan until or unless this Plan is approved by stockholders. The Plan shall continue in effect, unless sooner
terminated pursuant to Section 11.2, until the tenth (10<SUP>th</SUP>) anniversary of the Adoption Date. The provisions of the Plan shall
continue thereafter to govern all outstanding Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;Section 11.7&nbsp;<U>Governing
Law</U>. To the extent not preempted by federal law, the Plan shall be construed in accordance with and governed by the laws of the State
of Delaware regardless of the application of rules of conflict of law that would apply the laws of any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 11.8&nbsp;<U>Severability</U>.
In the event any portion of the Plan or any action taken pursuant thereto shall be held illegal or invalid for any reason, the illegality
or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid
provisions had not been included, and the illegal or invalid action shall be null and void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 11.9&nbsp;<U>Governing
Documents</U>. In the event of any express contradiction between the Plan and any Award Agreement or any other written agreement between
a Participant and the Company or any Affiliate that has been approved by the Administrator, the express terms of the Plan shall govern,
unless it is expressly specified in such Award Agreement or other written document that such express provision of the Plan shall not apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 11.10&nbsp;<U>Withholding
Taxes</U>. In addition to any rights or obligations with respect to the federal, state, local or foreign income taxes, withholding taxes
or employment taxes required to be withheld under applicable law, the Company or any Affiliate employing a Service Provider shall have
the right to withhold from the Service Provider, or otherwise require the Service Provider or an assignee to pay, any such required withholding
obligations arising as a result of grant, exercise, vesting or settlement of any Award or any other taxable event occurring pursuant to
the Plan or any Award Agreement, including, without limitation, to the extent permitted by law, the right to deduct any such withholding
obligations from any payment of any kind otherwise due to the Service Provider or to take such other actions (including, without limitation,
withholding any Shares or cash deliverable pursuant to the Plan or any Award) as may be necessary to satisfy such withholding obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 16 of 17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 11.11&nbsp;<U>Section
409A</U>. To the extent applicable, the Plan and Award Agreements shall be interpreted in accordance with Section 409A of the Code and
Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations
or other guidance that may be issued after the adoption of the Plan. Notwithstanding any provision of the Plan to the contrary, in the
event that following the adoption of the Plan, the Administrator determines that any Award may be subject to Section 409A of the Code
and related regulations and Department of Treasury guidance (including such Department of Treasury guidance as may be issued after the
adoption of the Plan), the Administrator may adopt such amendments to the Plan and the applicable Award Agreement or adopt other policies
and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Administrator
determines are necessary or appropriate to (a) exempt the Award from Section 409A of the Code and/or preserve the intended tax treatment
of the benefits provided with respect to the Award, (b) comply with the requirements of Section 409A of the Code and related Department
of Treasury guidance or (c) comply with any correction procedures available with respect to Section 409A of the Code. Notwithstanding
anything else contained in this Plan or any Award Agreement to the contrary, if a Service Provider is a &ldquo;specified employee&rdquo;
at the time of the Service Provider&rsquo;s &ldquo;separation from service&rdquo; (as determined under Section 409A of the Code) then,
to the extent necessary to comply with, and avoid imposition on such Service Provider of any tax penalty imposed under, Section 409A of
the Code, any payment required to be made to a Service Provider hereunder upon or following his or her separation from service shall be
delayed until the first to occur of (i) the six-month anniversary of the Service Provider&rsquo;s separation from service and (ii) the
Service Provider&rsquo;s death. Should payments be delayed in accordance with the preceding sentence, the accumulated payment that would
have been made but for the period of the delay shall be paid in a single lump sum during the ten (10) day period following the lapsing
of the delay period. No provision of this Plan or an Award Agreement shall be construed to indemnify any Service Provider for any taxes
incurred by reason of Section 409A (or timing of incurrence thereof), other than an express indemnification provision therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 11.12&nbsp;<U>Notices</U>.
Except as provided otherwise in an Award Agreement, all notices and other communications required or permitted to be given under this
Plan or any Award Agreement shall be in writing and shall be deemed to have been given if delivered personally, sent by email or any other
form of electronic transfer approved by the Administrator, sent by certified or express mail, return receipt requested, postage prepaid,
or by any recognized international equivalent of such delivery, (i) in the case of notices and communications to the Company, to its current
business address and to the attention of the Corporate Secretary of the Company or (ii) in the case of a Participant, to the last known
address, or email address or, where the individual is an employee of the Company or one of its Subsidiaries, to the individual&rsquo;s
workplace address or email address or by other means of electronic transfer acceptable to the Administrator. All such notices and communications
shall be deemed to have been received on the date of delivery, if sent by email or any other form of electronic transfer, at the time
of dispatch or on the third business day after the mailing thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 11.13&nbsp;<U>Beneficiary
Designation</U>. Each Participant under the Plan may from time to time pursuant to procedures approved by the Company name any beneficiary
or beneficiaries by whom any right under the Plan is to be exercised in case of such Participant&rsquo;s death.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Page 17 of 17</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>atnf-20240216.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWaiJWaPtyJ1xSYkxuG94fTka7ycpz3m+0CTwzgjW8egN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ATNF="http://180lifesciences.com/20240216" elementFormDefault="qualified" targetNamespace="http://180lifesciences.com/20240216">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://180lifesciences.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="atnf-20240216_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="atnf-20240216_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="atnf-20240216_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="ATNF_CommonStockParValue0.0001PerShareMember" name="CommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATNF_WarrantsToPurchaseSharesOfCommonStockMember" name="WarrantsToPurchaseSharesOfCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>atnf-20240216_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://180lifesciences.com/role/Cover" xlink:href="atnf-20240216.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://180lifesciences.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atnf-20240216.xsd#ATNF_CommonStockParValue0.0001PerShareMember" xlink:label="loc_ATNFCommonStockParValue0.0001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATNFCommonStockParValue0.0001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="atnf-20240216.xsd#ATNF_WarrantsToPurchaseSharesOfCommonStockMember" xlink:label="loc_ATNFWarrantsToPurchaseSharesOfCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATNFWarrantsToPurchaseSharesOfCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>atnf-20240216_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="atnf-20240216.xsd#ATNF_CommonStockParValue0.0001PerShareMember" xlink:label="ATNF_CommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATNF_CommonStockParValue0.0001PerShareMember" xlink:to="ATNF_CommonStockParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATNF_CommonStockParValue0.0001PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="atnf-20240216.xsd#ATNF_WarrantsToPurchaseSharesOfCommonStockMember" xlink:label="ATNF_WarrantsToPurchaseSharesOfCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATNF_WarrantsToPurchaseSharesOfCommonStockMember" xlink:to="ATNF_WarrantsToPurchaseSharesOfCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATNF_WarrantsToPurchaseSharesOfCommonStockMember_lbl" xml:lang="en-US">Warrants to purchase shares of Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>atnf-20240216_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://180lifesciences.com/role/Cover" xlink:href="atnf-20240216.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://180lifesciences.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atnf-20240216.xsd#ATNF_CommonStockParValue0.0001PerShareMember" xlink:label="loc_ATNFCommonStockParValue0.0001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATNFCommonStockParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atnf-20240216.xsd#ATNF_WarrantsToPurchaseSharesOfCommonStockMember" xlink:label="loc_ATNFWarrantsToPurchaseSharesOfCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATNFWarrantsToPurchaseSharesOfCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139922212679728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 16, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 16,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">180 LIFE SCIENCES
CORP.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001690080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">90-1890354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3000 El Camino Real<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">&#160;Bldg. 4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">&#160;Suite
    200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Palo
    Alto<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">507-0669<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ATNF_CommonStockParValue0.0001PerShareMember', window );">Common Stock, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATNF<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ATNF_WarrantsToPurchaseSharesOfCommonStockMember', window );">Warrants to purchase shares of Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to purchase shares of Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATNFW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ATNF_CommonStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ATNF_CommonStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ATNF_WarrantsToPurchaseSharesOfCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ATNF_WarrantsToPurchaseSharesOfCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M _([_A)\IX^.B7V4E93?[<D\'#K4$O&(!\9*,/AZYA,>158)./XYB#K%?]K
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MM-)MW+/LID!;2&V@B?XMTI-3OT:QWV[1+L96.H^+6T8^CF-8"9]&P06Z';3
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ Z8%06*K$(A8S 0  (@(
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M%S?W1:[-XPFNWPQP>'3^ 5!+ P04    " #I@5!899!YDAD!  #/ P  $P
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MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ Z8%06)E<G",0!@
MG"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    " #I@5!8T2<;'L8$  "Q%   &               @($-"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ Z8%06.#T.HFJ @
M, P   T              ( !"0T  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M" #I@5!8EXJ[',     3 @  "P              @ '>#P  7W)E;',O+G)E
M;'-02P$"% ,4    " #I@5!8JL0B%C,!   B @  #P              @ ''
M$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ Z8%06"0>FZ*M    ^ $
M !H              ( !)Q(  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ Z8%06&60>9(9 0  SP,  !,              ( !#!,
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  5A0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea193928-8k_180life.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://180lifesciences.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>atnf-20240216.xsd</File>
    <File>atnf-20240216_def.xml</File>
    <File>atnf-20240216_lab.xml</File>
    <File>atnf-20240216_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea193928-8k_180life.htm">ea193928-8k_180life.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea193928-8k_180life.htm": {
   "nsprefix": "ATNF",
   "nsuri": "http://180lifesciences.com/20240216",
   "dts": {
    "schema": {
     "local": [
      "atnf-20240216.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "atnf-20240216_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "atnf-20240216_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "atnf-20240216_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea193928-8k_180life.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 27
   },
   "report": {
    "R1": {
     "role": "http://180lifesciences.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-16",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea193928-8k_180life.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-02-16",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea193928-8k_180life.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "auth_ref": []
    },
    "ATNF_CommonStockParValue0.0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://180lifesciences.com/20240216",
     "localname": "CommonStockParValue0.0001PerShareMember",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.0001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ATNF_WarrantsToPurchaseSharesOfCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://180lifesciences.com/20240216",
     "localname": "WarrantsToPurchaseSharesOfCommonStockMember",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants to purchase shares of Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001213900-24-014908-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-24-014908-xbrl.zip
M4$L#!!0    ( .F!4%A$[>#!T@,  .H.   1    871N9BTR,#(T,#(Q-BYX
M<V2]5]MRVS80?>],_P'E:X<B*>5B,U(RJ3WV*&,[&DN)[;YD('(IH2(!!@ M
M.5^?!6_6E9'4NGH"%^?L!=A=K+H?%DE,'D$J)GC/\EJN18 '(F1\TK.^#.V/
MP[-^WR(?WO_^&\%?]P_;)A<,XM GYR*P^SP2[\@-3< GE\!!4BWD._*5QIF1
MB L6@R1G(DECT( ;A26?O&ZU/4IL>P^]7X&'0GZY[==ZIUJGRG><^7S>XN*1
MSH6<J58@DOT4#C75F:JUN0NW_.U'OV8JJ,G.]_1O]79QR^XGP$^ROQ[N']0=
M99_NZ$ _??(6PX?9(KL\?16-9O3M4Y#^Z"1_NF>C^8_)/W<G,+DI3'95,(6$
M$KP,KGJ6B:\,;]YI"3EQVJ[K.??75\,<9Q5 ?Q$S/ML&]TY/3YU\MX)N(!=C
M&5>J.X[9'E,%M6;<90UXQI6F/%C!A[HF+(-?.\7F"I1MA;XIH*R"AK"&4Q"T
M)N+1P0W$MSL5,%/VA-*T!D=4C7.EY<8*6$F]"43A.LC63RFHK=!B:X40:KE&
M6#DUW';,MN&T;;=C=[R*^7%T<U&3O!,W9A&H@&$90I[4AO+*;7MOL#1C2(#K
M"R&3<XAH%F,DWS.*# :A1325$] F2U5* ]A/:97QE'.!A8'564J,+$T99GXM
M0)')%%^*&$88#3$+K,Q&2P;CG EL,A9A8<\JEDLZ*ZTA1(RSW(.R(#UBF_++
M3-"XS)E=9QV\J2E3$'[F[_-U*D$A/8_L"@4EOX0T<P,:!UE\%/79OR9F*:_.
M<^.@J[J\A8CD]>R;).I9BIF.:I6RJ82H9U'-([NZUF\8=@OSJX(8"PWUG-_1
M^DF5ABL55 8;6C;Z#2H1*4C-L#R6FDKA.M.&/E@R0XP=91'G/XP\IN-#(T<*
MQ"\8\I71_Q*Q8I8=&NMJ8KY0P.>UD<VHN\YJ6\'O]=;3Q<"%U(1OM+*FIZAX
M1*]$D*MJH)@ON^+91F1[;>S(K84*GST]Q(GG8SC,B8IWA!,['L1M]M4NN%F8
M9.KL:W3'P]IH="O'@5BK2G*T"\O/\+_P(5=SD!._?MMWN?,K9OZMCDJ"0&1<
MRZ=#$F&94GT<=QO/ ]1^%U'ABTLP,]6Q9H_(@DWC.U.@'+GRR<5,:M_PSTPB
M^%"+8#:@,O\;X+;,K#( .9Q2"=>0C,VL8[PVT\Z^<!;C,V2:IY:9Z:=F!/>Q
MSS(1CO+G(,QD'A4.>L5W-7+ZH4@HXWT-B4'B*61CA9TX,^A+*3*<C MU#"%-
MP=U1*2G7:B0&F0RFV)ER']7G:"F.U0 /H_R_07:=(A]P^1-02P,$%     @
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M(^%IS.C;P?CH>( (C=@BIJNW@T_3X=GT_.IJ@-(,TP5.&"5O!Y0-?OGYCW]
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MW:(!&:VS8:H"@@.P!M"1J]'TZMSG2#+#NZN% #5>QGJ-7@<EH-XM+!VVZ\P
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MEZV"0-ODO?UV\XW[X?ZZ@3WR-U!+ P04    " #I@5!8(L1LV*X<  !MS
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M2!]J6A_:KCS%"P2?@44&LVPG*\,?XS,V?/?'^XN[TL:581:'L":47U@3IMB
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M-E6!/4K%EIT%-B5FSWO<!B9/M#V4 D(5F,1[H;H >^U6\U5$K4RU#!=SI/&
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M1:>()YJU?;DHUS E^,J^?A_.=I5<MLU-?T5#P1G %,JLPE'@?,-I''S<&_1
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M6X,16K/EP8B@!\PWH+J^$Y=\*E8EJ-7K3;N&+6)GQ6!HVCT2ZO!7UG4;R?S
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MY,G7$__@$W^TY<2)%XZJ]5[["._H3J5WW&_G%KF74G:4GQG/WS0N0!_1(#O
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MXN]4H><2*=$^A[LQG?A/(D-U#3M=&PSC#CR03=E1QNHR%YYS1U(2Y;%DP*=
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M)IR&% 1\RDKPT>DCJVGJ*H#+L0JL!0HQ5]#B]EH-0M\U3FC2;6="Y462WP<
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ML-YHRW8:E)E1FN:S(:^F85WC1-X::, <)XB>K6&;#:3^5+%/:NH446Y3!QQ
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ML=) 3FI,Q_4+WYT#\Q(1OVH3-_(45X&L+NDNI"[;C0XU1N:\!I'N2EG)+#Z
M& W:@1KLM,<N8@OW(SCDB<.HF<N=<Q#U>%"@%PRA5*<34IW>5[=> ),'N=!B
M&RD7"J#D%%@57H"R, K\=5%G,4I24$APD9'58EKDQZY%>&!JPOE_6R7AK7(
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MVK:G/L"1\FKHHJ3%%*7<I(%&:Q/"A8JG$R%C3NPP*H;1@KAB/!NF;<,<Q#E
MVIME=JLLY]!@/ M]9 ._TK *D+T4JV?0/ _40FE7KC+G%!NK775IG)LQ_9<U
M:<S7?%RJJE>_RY67FPY7#H'$KU8 3KAW=#@CA+9.+M=56-RZF[ 4H%*ZM!7>
M$)(6M*&45_(JB&E3S7K=\>[BSU139%WT[>K^'4O(N,K8R=N%'JQ1?7E)Z>=6
M.E*:;$QD5_7!XRP3K/VPC6>YL:)G/:E)S M3 L+)7%2][!A=B"AMW\$%)NXE
M"<+T8V)_AX9D2=YLLR;T]Q+'5$V&FV"IN!C3S$J@%%OZ%:*NP[@" 6A*S4QA
M#1G%)MNAR$W5C?-@AY +T>C5K3CHX:MVW5 NJ$![JS*IU%9XHUG)C0P4. +[
M8/UIVJ-OG,]W,-G(C$CK68"F9;P"9#\NK@BX4? ;5T5[B7X)/#UT=AJ*45UT
M;<;-?--A,2"V+3((HC"_HK<"TZR;_!G+$MWS]),&C-U/CU#SD,Q+!_!\VN__
M%S6W.+-E67S/O=OE]&S'HITN@)H@4R3?/C@\;) <:[K@%$RNL>9T<JX/E8N"
M042^*:/7-& %SNU%CK EAOA-#V1#F$;_9\U?*SRC;YA.W"M2B95A.2 N=WZK
ME'W$MVFO*7.8?&U T@A907G[>NG*+ Q VVY #^L:5,Q2.W,/SWIW2=6A[SVG
M%JW FKC'^(6+*?Z2W2CIQ!R1LG[9.F=*H_A<[T4271:R[4\6X@,5^CVGB]X&
M6L]L%I;Y5/<F:(O+396Y@%N[J2@QI%EMJLO,J35";3@@6E*7#;%D?Y:>/3]V
M 3C+6I-;.;"ZU=IZDV8?="?&\?G>BTM;'F5/=6M:2'B2-A,KIV@)4Q27&R9/
MV3;VTMA<MP5("0Z&8LSH-\[@!R W6H'U40='7Z.',Y7M9)P?N]%!G)C*9V/=
MAMF];->AYFNF&3(T:CI=8+FV\0B-T=%PQMS;>&S*#^!:;PMI/OZ"0YJ/=S>D
M^2 8N\/)>VM*S/$^!GS\)NN2,/H@N"_8U*2%\9J!VQ.+9D[7;5DEQT_2Y/CP
M^#C9ZP=E6<:(0:MP4(6%Q5XNPR'B%U1S=,5'UM(4S<>4YE 3*>-0E%5L<=N:
M#!6<.3+4&M,F5D5ABL"\1X<K\PW><&FQ%C:A=Q,,_\QGX6 9<1].T$S&@-\8
MG:!I72=S:Y_XAZCG/]A'JQ1:F]"V1N^:IJ9L>N=K'XE ':<*R11Y]!6Z!GZZ
M^/7U,^R!B/^=Q4 3/*+@J0TU C=9\EGQ;'O;38<,.^I SFGI Q"UA\#U/_F;
MU>$XS,&_FD;MTPGH<'+U?=$*END:#0V#!;4L<FHUX OQB-D?(W,$)J17.F9B
M0J:DZO6F+\2+HL(+@*6+EW!D7 SL8;L;(YCE.M?&+JN2T_D0ZTW%%_ 1_VW.
MC? /4"Z[G*L:=HPP%$DX*+$+M()T[S1$366*N![)_M.VJ902]]GO1:V8@U1(
M.Y0?1+4!N]?D"I0U<.8R#^PR)C#Y&=D=[J<(TS#P>)%E235Y>-LQ8N4Q#9>F
M.4:TC*L#LUAP]9W4-P]G*I&X3B!I<I>>SJX=TZ,Y_K39IG@VP^Z2X0\QSO3"
MX-,R?_*H4:ZR^ +$3)+;[/7)L*9&S('BY:^8H%YFOY9Q0!,(7"EYS'EAS4)3
MN] Q781:5 10SRS#AIT"4F7>F2*N-W'$DJQ,YPCQNH\H<"UOI?XJ#?AOXM!6
MS"PL@4=F0G<.N>KNTNK1H256;,:&ZA21Z]OL7>%(-<OSTL3ZQX.[,>PY$;3H
M725,T*H1N"NTAF"FR&BP8JW'][';2N; 'Q&S5&!/]*&'FC-GL4R\.!9E3[>3
M-X_-F$NADUW(A)NS.K\_YKS+/%U\*'PV]?,]-%+VX#4T*4F+*PJ! DH=KJ1=
M[HT^(KWU&8A_J=O6$'FD8Z?62^)@.@+L(@T-[K$1V&[:1^%3!(-!0LDIS+PS
M6SR[7IP@!IWLNT$\?XL]/[OS(),V$A6BO1G=$CH9DO,.1@W__+TT.?&<M.D
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M?U!+ 0(4 Q0    ( .F!4%A$[>#!T@,  .H.   1              "  0
M  !A=&YF+3(P,C0P,C$V+GAS9%!+ 0(4 Q0    ( .F!4%AOHO1: 0D  )5H
M   5              "  0$$  !A=&YF+3(P,C0P,C$V7V1E9BYX;6Q02P$"
M% ,4    " #I@5!8[Q!X9.\+   4D   %0              @ $U#0  871N
M9BTR,#(T,#(Q-E]L86(N>&UL4$L! A0#%     @ Z8%06*+%L4E)"   +V,
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%G0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>ea193928-8k_180life_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ATNF="http://180lifesciences.com/20240216"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="atnf-20240216.xsd" xlink:type="simple"/>
    <context id="AsOf2024-02-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001690080</identifier>
        </entity>
        <period>
            <startDate>2024-02-16</startDate>
            <endDate>2024-02-16</endDate>
        </period>
    </context>
    <context id="From2024-02-162024-02-16_custom_CommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001690080</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATNF:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-16</startDate>
            <endDate>2024-02-16</endDate>
        </period>
    </context>
    <context id="From2024-02-162024-02-16_custom_WarrantsToPurchaseSharesOfCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001690080</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATNF:WarrantsToPurchaseSharesOfCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-16</startDate>
            <endDate>2024-02-16</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-02-16" id="ixv-523">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-02-16" id="ixv-524">0001690080</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-02-16" id="ixv-560">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-02-16" id="ixv-561">2024-02-16</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-02-16" id="ixv-562">180 LIFE SCIENCES CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-02-16" id="ixv-563">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-02-16" id="ixv-564">001-38105</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-02-16" id="ixv-565">90-1890354</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-02-16" id="ixv-566">3000 El Camino Real</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-02-16" id="ixv-567">&#160;Bldg. 4</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="AsOf2024-02-16" id="ixv-568">&#160;Suite     200</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-02-16" id="ixv-569">Palo     Alto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-02-16" id="ixv-570">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-02-16" id="ixv-571">94306</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-02-16" id="ixv-572">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-02-16" id="ixv-573">507-0669</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-02-16" id="ixv-574">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-02-16" id="ixv-575">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-02-16" id="ixv-576">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-02-16" id="ixv-577">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2024-02-162024-02-16_custom_CommonStockParValue0.0001PerShareMember"
      id="ixv-578">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-02-162024-02-16_custom_CommonStockParValue0.0001PerShareMember"
      id="ixv-579">ATNF</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-02-162024-02-16_custom_CommonStockParValue0.0001PerShareMember"
      id="ixv-580">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2024-02-162024-02-16_custom_WarrantsToPurchaseSharesOfCommonStockMember"
      id="ixv-581">Warrants to purchase shares of Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-02-162024-02-16_custom_WarrantsToPurchaseSharesOfCommonStockMember"
      id="ixv-582">ATNFW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-02-162024-02-16_custom_WarrantsToPurchaseSharesOfCommonStockMember"
      id="ixv-583">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-02-16" id="ixv-584">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
